Reynoso Jamie L.

Insider

CEO, Medicare Advantage

Trades at: CLOV

30D 90D 1Y

Net shares · 365d

-115.9K

0 buy · 115.9K sell

Net value · 365d

-$367.7K

$0 in · $367.7K out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 115.9K sell

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 365d

Open-market Buys Sells All types

CLOV Sell·S
Jun 17, 26

CEO, Medicare Advantage · 10b5-1

$11.3K

2.4K sh · $4.78

Own -0%
CLOV Sell·S
Jun 15, 26

CEO, Medicare Advantage · 10b5-1

$29.3K

6.3K sh · $4.61

Own -0%
CLOV Sell·S
Jun 11, 26

CEO, Medicare Advantage · 10b5-1

$35.8K

7.3K sh · $4.91

Own -0%
CLOV Other·F
Apr 15, 26

CEO, Medicare Advantage

$25.9K

12.7K sh · $2.04

Own -0%
CLOV Other·F
Apr 3, 26

CEO, Medicare Advantage

$10.7K

6.2K sh · $1.72

Own -0%
CLOV Grant·A
Apr 1, 26

CEO, Medicare Advantage

$0

159.4K sh

Own +6%
CLOV Sell·S
Mar 18, 26

CEO, Medicare Advantage · 10b5-1

$11.1K

5.8K sh · $1.91

Own -0%
CLOV Other·F
Mar 15, 26

CEO, Medicare Advantage

$30.0K

15.1K sh · $1.98 avg · 2 lots

Own -1%
CLOV Sell·S
Jan 20, 26

CEO, Medicare Advantage · 10b5-1

$11.9K

4.6K sh · $2.58

Own -0%
CLOV Other·F
Jan 15, 26

CEO, Medicare Advantage · 10b5-1

$41.4K

14.7K sh · $2.81

Own -1%
CLOV Sell·S
Jan 7, 26

CEO, Medicare Advantage · 10b5-1

$5.3K

2.1K sh · $2.53

Own -0%
CLOV Other·F
Jan 3, 26

CEO, Medicare Advantage

$19.5K

8.1K sh · $2.41

Own -0%
CLOV Sell·S
Dec 18, 25

CEO, Medicare Advantage · 10b5-1

$12.8K

4.9K sh · $2.61

Own -0%
CLOV Other·F
Dec 15, 25

CEO, Medicare Advantage

$57.4K

21.3K sh · $2.70 avg · 2 lots

Own -1%
CLOV Sell·S
Nov 4, 25

CEO, Medicare Advantage · 10b5-1

$108.8K

30.4K sh · $3.58

Own -1%
CLOV Other·F
Oct 31, 25

CEO, Medicare Advantage

$463.9K

131.4K sh · $3.53 avg · 2 lots

Own -4%
CLOV Sell·S
Oct 17, 25

CEO, Medicare Advantage · 10b5-1

$44.4K

16.5K sh · $2.69

Own -1%
CLOV Other·F
Oct 15, 25

CEO, Medicare Advantage

$200.0K

71.4K sh · $2.80

Own -2%
CLOV Sell·S
Oct 7, 25

CEO, Medicare Advantage · 10b5-1

$5.3K

2.0K sh · $2.65

Own -0%
CLOV Other·F
Oct 3, 25

CEO, Medicare Advantage · 10b5-1

$22.5K

8.7K sh · $2.59

Own -0%
CLOV Sell·S
Sep 17, 25

CEO, Medicare Advantage · 10b5-1

$15.2K

4.9K sh · $3.09

Own -0%
CLOV Other·F
Sep 15, 25

CEO, Medicare Advantage

$65.7K

21.3K sh · $3.09 avg · 2 lots

Own -1%
CLOV Sell·S
Aug 4, 25

CEO, Medicare Advantage · 10b5-1

$19.7K

6.8K sh · $2.89

Own -0%
CLOV Other·F
Jul 31, 25

CEO, Medicare Advantage

$85.3K

29.5K sh · $2.89

Own -1%
CLOV Sell·S
Jul 7, 25

CEO, Medicare Advantage · 10b5-1

$56.8K

21.8K sh · $2.60 avg · 2 lots

Own -1%
CLOV Other·F
Jul 3, 25

CEO, Medicare Advantage · 10b5-1

$22.3K

8.7K sh · $2.56

Own -0%
CLOV Grant·A
Jun 30, 25

CEO, Medicare Advantage

$0

217.5K sh

Own +7%
CLOV Other·F
Jun 30, 25

CEO, Medicare Advantage

$238.8K

85.6K sh · $2.79

Own -3%
CLOV Other·F
Jun 30, 25

CEO, Medicare Advantage

$238.8K

85.6K sh · $2.79

Own -3%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	CLOV	CEO, Medicare Advantage	Sell S	2.4K	-0%	$4.78	$11.3K
Jun 15, 2026	CLOV	CEO, Medicare Advantage	Sell S	6.3K	-0%	$4.61	$29.3K
Jun 11, 2026	CLOV	CEO, Medicare Advantage	Sell S	7.3K	-0%	$4.91	$35.8K
Apr 15, 2026	CLOV	CEO, Medicare Advantage	Other F	12.7K	-0%	$2.04	$25.9K
Apr 3, 2026	CLOV	CEO, Medicare Advantage	Other F	6.2K	-0%	$1.72	$10.7K
Apr 1, 2026	CLOV	CEO, Medicare Advantage	Grant A	159.4K	+6%	—	$0
Mar 18, 2026	CLOV	CEO, Medicare Advantage	Sell S	5.8K	-0%	$1.91	$11.1K
Mar 15, 2026	CLOV	CEO, Medicare Advantage	Other F	15.1K · 2 lots	-1%	$1.98 avg	$30.0K
Jan 20, 2026	CLOV	CEO, Medicare Advantage	Sell S	4.6K	-0%	$2.58	$11.9K
Jan 15, 2026	CLOV	CEO, Medicare Advantage	Other F	14.7K	-1%	$2.81	$41.4K
Jan 7, 2026	CLOV	CEO, Medicare Advantage	Sell S	2.1K	-0%	$2.53	$5.3K
Jan 3, 2026	CLOV	CEO, Medicare Advantage	Other F	8.1K	-0%	$2.41	$19.5K
Dec 18, 2025	CLOV	CEO, Medicare Advantage	Sell S	4.9K	-0%	$2.61	$12.8K
Dec 15, 2025	CLOV	CEO, Medicare Advantage	Other F	21.3K · 2 lots	-1%	$2.70 avg	$57.4K
Nov 4, 2025	CLOV	CEO, Medicare Advantage	Sell S	30.4K	-1%	$3.58	$108.8K
Oct 31, 2025	CLOV	CEO, Medicare Advantage	Other F	131.4K · 2 lots	-4%	$3.53 avg	$463.9K
Oct 17, 2025	CLOV	CEO, Medicare Advantage	Sell S	16.5K	-1%	$2.69	$44.4K
Oct 15, 2025	CLOV	CEO, Medicare Advantage	Other F	71.4K	-2%	$2.80	$200.0K
Oct 7, 2025	CLOV	CEO, Medicare Advantage	Sell S	2.0K	-0%	$2.65	$5.3K
Oct 3, 2025	CLOV	CEO, Medicare Advantage	Other F	8.7K	-0%	$2.59	$22.5K
Sep 17, 2025	CLOV	CEO, Medicare Advantage	Sell S	4.9K	-0%	$3.09	$15.2K
Sep 15, 2025	CLOV	CEO, Medicare Advantage	Other F	21.3K · 2 lots	-1%	$3.09 avg	$65.7K
Aug 4, 2025	CLOV	CEO, Medicare Advantage	Sell S	6.8K	-0%	$2.89	$19.7K
Jul 31, 2025	CLOV	CEO, Medicare Advantage	Other F	29.5K	-1%	$2.89	$85.3K
Jul 7, 2025	CLOV	CEO, Medicare Advantage	Sell S	21.8K · 2 lots	-1%	$2.60 avg	$56.8K
Jul 3, 2025	CLOV	CEO, Medicare Advantage	Other F	8.7K	-0%	$2.56	$22.3K
Jun 30, 2025	CLOV	CEO, Medicare Advantage	Grant A	217.5K	+7%	—	$0
Jun 30, 2025	CLOV	CEO, Medicare Advantage	Other F	85.6K	-3%	$2.79	$238.8K
Jun 30, 2025	CLOV	CEO, Medicare Advantage	Other F	85.6K	-3%	$2.79	$238.8K

Buy Sell Non-market (grant · exercise · gift)

About Reynoso Jamie L.

This profile aggregates every SEC Form 4 insider transaction reported by Reynoso Jamie L. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.